- Home
- TMO vs MS Comparison
TMO vs MS Comparison
Compare TMO & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TMO | MS |
|---|---|---|
| Founded | 1956 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 216.4B | 278.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TMO | MS |
|---|---|---|
| Price | $623.83 | $191.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | ★ $637.78 | $175.33 |
| AVG Volume (30 Days) | 1.9M | ★ 5.0M |
| Earning Date | 01-29-2026 | 01-15-2026 |
| Dividend Yield | 0.28% | ★ 2.21% |
| EPS Growth | 8.54 | ★ 48.48 |
| EPS | ★ 17.32 | 9.75 |
| Revenue | $43,736,000,000.00 | ★ $68,532,000,000.00 |
| Revenue This Year | $4.33 | $17.72 |
| Revenue Next Year | $4.98 | $6.46 |
| P/E Ratio | $35.91 | ★ $18.54 |
| Revenue Growth | 3.22 | ★ 17.59 |
| 52 Week Low | $385.46 | $94.33 |
| 52 Week High | $628.08 | $188.82 |
Technical Indicators
Market Signals| Indicator | TMO | MS |
|---|---|---|
| Relative Strength Index (RSI) | 65.34 | 66.41 |
| Support Level | $594.30 | $178.93 |
| Resistance Level | $624.79 | $187.27 |
| Average True Range (ATR) | 13.84 | 3.71 |
| MACD | 2.46 | -0.02 |
| Stochastic Oscillator | 91.47 | 98.48 |
Price Performance
Historical ComparisonAbout TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
About MS Morgan Stanley
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.